Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo
- 1 September 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 104 (5), 1411-1418
- https://doi.org/10.1182/blood-2004-01-0267
Abstract
Antineutrophil cytoplasmic autoantibodies (ANCAs) recognizing human proteinase 3 of neutrophil granules are a diagnostic hallmark of Wegener granulomatosis, an autoimmune systemic vasculitis with predilection for the respiratory tract and kidneys. In vitro experiments have implicated several mechanisms by which ANCAs may lead to tissue injury. However, little is known about the pathogenic significance of proteinase 3–specific antibodies in vivo. In vivo models for ANCA-mediated proinflammatory effects have not been forthcoming, primarily because ANCA epitopes on human proteinase 3 are not shared by the murine homolog. In this study we generated ANCAs against recombinant murine proteinase 3 in proteinase 3/neutrophil elastase–deficient mice that recognized the murine antigen on the surface of neutrophils. Local inflammation induced by intradermal injection of tumor necrosis factor α triggered a stronger subcutaneous panniculitis in the presence of passively transferred systemic proteinase 3–ANCAs than in the presence of mock immune serum. When we transferred mouse proteinase 3-ANCA serum to systemically lipopolysaccharide-primed wild-type mice, mice treated with proteinase 3-ANCAs did not develop significantly stronger signs of inflammation of the lungs or kidneys than the respective mock immune serum-treated animals. In conclusion, our in vivo study provides the first evidence for a pathogenic effect of proteinase 3–specific ANCAs at local sites of inflammation.This publication has 35 references indexed in Scilit:
- Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infectionClinical and Experimental Immunology, 2002
- Cocaine-Induced Midline Destructive LesionsMedicine, 2001
- Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitisKidney International, 2001
- Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti‐proteinase 3 and anti‐myeloperoxidase autoantibodiesJournal of Internal Medicine, 1998
- Animal models of anti-neutrophil cytoplasmic antibody associated vasculitisKidney International, 1998
- Antineutrophil Cytoplasmic Autoantibodies Interact with Primary Granule Constituents on the Surface of Apoptotic Neutrophils in the Absence of Neutrophil PrimingThe Journal of Experimental Medicine, 1996
- Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.The Journal of Experimental Medicine, 1996
- Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's GranulomatosisThe New England Journal of Medicine, 1996
- Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model.The Journal of Experimental Medicine, 1993
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992